Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
PHASE3CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
November 30, 1996
Study Completion Date
September 30, 2005
Conditions
Graft vs Host DiseaseMultiple Myeloma
Interventions
DRUG
Myeloma Immunoglobulin Idiotype Vaccine-KLH
DRUG
GM-CSF
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001561 - Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation | Biotech Hunter | Biotech Hunter